Inventor · disambiguated record
Keith A. Bostian
Also filed as: BOSTIAN KEITH · BOSTIAN KEITH A
22 granted patents·10 pending applications·216 citations·filing 1992–2021
96Inventor score
Files withMPEX PHARMACEUTICALS INC7HORIZON ORPHAN LLC5MOTIF BIOSCIENCES INC3RAPTOR PHARMACEUTICALS INC3SURBER MARK W3
Top patents by PatentIndex Score
32 records- 0194US8357696B2Aerosolized fluoroquinolones and uses thereofMPEX PHARMACEUTICALS INC·Filed 2010·Granted Jan 22, 2013·20 cites·43 claims
- 0294US7838532B2Aerosolized fluoroquinolones and uses thereofMPEX PHARMACEUTICALS INC·Filed 2006·Granted Nov 23, 2010·34 cites·84 claims
- 0392US8524734B2Aerosolized fluoroquinolones and uses thereofSURBER MARK W·Filed 2009·Granted Sep 3, 2013·13 cites·39 claims
- 0491US8815838B2Aerosol fluoroquinolone formulations for improved pharmacokineticsGRIFFITH DAVID C·Filed 2009·Granted Aug 26, 2014·18 cites·80 claims
- 0591US8546423B2Aerosolized fluoroquinolones and uses thereofSURBER MARK W·Filed 2009·Granted Oct 1, 2013·12 cites·41 claims
- 0690US9717738B2Aerosol fluoroquinolone formulations for improved pharmacokineticsRAPTOR PHARMACEUTICALS INC·Filed 2016·Granted Aug 1, 2017·6 cites·29 claims
- 0790US8524735B2Aerosolized fluoroquinolones and uses thereofSURBER MARK W·Filed 2009·Granted Sep 3, 2013·10 cites·16 claims
- 0889US7893020B2Bacterial efflux pump inhibitors and methods of treating bacterial infectionsMPEX PHARMACEUTICALS INC·Filed 2005·Granted Feb 22, 2011·13 cites·25 claims
- 0988US9326936B2Aerosol fluoroquinolone formulations for improved pharmacokineticsRAPTOR PHARMACEUTICALS INC·Filed 2014·Granted May 3, 2016·7 cites·17 claims
- 1088US7054755B2Interactive correlation of compound information and genomic informationICONIX PHARM INC·Filed 2001·Granted May 30, 2006·29 cites·14 claims
- 1187US10987357B2Aerosolized fluoroquinolones and uses thereofHORIZON ORPHAN LLC·Filed 2019·Granted Apr 27, 2021·1 cites·13 claims
- 1285US8268865B2Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereofGLINKA TOMASZ·Filed 2008·Granted Sep 18, 2012·6 cites·58 claims
- 1384US10149854B2Aerosol fluoroquinolone formulations for improved pharmacokineticsHORIZON ORPHAN LLC·Filed 2017·Granted Dec 11, 2018·2 cites·20 claims
- 1484US7947741B2Use and administration of bacterial efflux pump inhibitorsMPEX PHARMACEUTICALS INC·Filed 2005·Granted May 24, 2011·8 cites·38 claims
- 1583US7994225B2Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infectionsREMPEX PHARMACEUTICALS INC·Filed 2007·Granted Aug 9, 2011·6 cites·17 claims
- 1682US10722519B2Aerosol fluoroquinolone formulations for improved pharmacokineticsHORIZON ORPHAN LLC·Filed 2018·Granted Jul 28, 2020·1 cites·10 claims
- 1782US7879795B2Enhancement of tigecycline potency using efflux pump inhibitorsMPEX PHARMACEUTICALS INC·Filed 2007·Granted Feb 1, 2011·2 cites·24 claims
- 1879US10076522B2Systems and methods for treating bacterial infectionMOTIF BIOSCIENCES INC·Filed 2017·Granted Sep 18, 2018·5 cites·29 claims
- 1972US2021121472A1Aerosol fluoroquinolone formulations for improved pharmacokineticsHORIZON ORPHAN LLC·Filed 2020·Application pending·0 cites
- 2063US2014066441A1Aerosolized fluoroquinolones and uses thereofMPEX PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2162US2020038399A1Formulations, methods, kit, and dosage forms for treating bacterial infectionMOTIF BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 2261US2016279138A1Aerosolized fluoroquinolones and uses thereofRAPTOR PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2360US2005060102A1Interactive correlation of compound information and genomic informationFiled 2004·Application pending·0 cites
- 2459US6322973B1Surrogate genetics target characterization methodICONIX PHARM INC·Filed 1998·Granted Nov 27, 2001·14 cites·5 claims
- 2556US2022047604A1Aerosolized fluoroquinolones and uses thereofHORIZON ORPHAN LLC·Filed 2021·Application pending·0 cites
- 2655US2018133218A1Formulations, methods, kit, and dosage forms for treating bacterial infectionMOTIF BIOSCIENCES INC·Filed 2017·Application pending·0 cites
- 2750US2008318957A1Polybasic bacterial efflux pump inhibitors and therapeutic uses thereofMPEX PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2849US8178490B2Polybasic bacterial efflux pump inhibitors and therapeutic uses thereofGLINKA TOMASZ·Filed 2009·Granted May 15, 2012·0 cites·15 claims
- 2947US5962249ASized-based marker identification technologyMICROCIDE PHARMACEUTICALS INC·Filed 1996·Granted Oct 5, 1999·6 cites·34 claims
- 3037US5324659AYeast mutants useful for indentifying immunosupressantsMERCK & CO INC·Filed 1992·Granted Jun 28, 1994·3 cites·1 claims
- 3134US2012237564A1Use of Aerosolized Antibiotics for Treating Chronic Obstructive Pulmonary DiseaseDUDLEY MICHAEL N·Filed 2012·Application pending·0 cites
- 3226US2001006794A1Screening for modulators of biomoleculesFiled 1998·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →